The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
Courvoisier DS, Chatzidionysiou K, Mongin D, Lauper K, Mariette X, Morel J, Gottenberg JE, Bergstra SA, Suarez MP, Codreanu C, Kvien TK, Santos MJ, Pavelka K, Hetland ML, Askling J, Turesson C, Kubo S, Tanaka Y, Iannone F, Choquette D, Nordström DC, Rotar Z, Lukina G, Gabay C, Van Vollenhoven R, Finckh A.
Courvoisier DS, et al. Among authors: mongin d.
Rheumatology (Oxford). 2021 Feb 1;60(2):820-828. doi: 10.1093/rheumatology/keaa393.
Rheumatology (Oxford). 2021.
PMID: 32810263